Journal Article Bioavailability and pharmacokinetics of cefoxitin sodium Get access J. J. Schrogie, J. J. Schrogie Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar R. O. Davies, R. O. Davies Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar K. C. Yeh, K. C. Yeh Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar D. Rogers, D. Rogers Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar G. I. Holmes, G. I. Holmes Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar H. Skeggs, H. Skeggs Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar C. M. Martin C. M. Martin Merck Sharp and Dohme Research LaboratoriesWest Point, Pennsylvania, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar Journal of Antimicrobial Chemotherapy, Volume 4, Issue suppl_B, 1978, Pages 69–78, https://doi.org/10.1093/jac/4.suppl_B.69 Published: 01 August 1978
No takes yet. Share an insight, caveat, or question.
Schrogie et al. (1978) studied this question.